BLOG

Key Research Findings Selank demonstrates 39.6% reduction in morphine withdrawal syndrome severity in controlled studies This anxiolytic peptide operates through GABA receptor modulation without dependency risk Clinical trials show significant stress response...

Key Research Findings Phase 2 trials demonstrate up to 24.2% mean weight loss after 48 weeks in obesity research Triple mechanism targets GLP-1, GIP, and glucagon receptors simultaneously for enhanced metabolic effects 82% reduction in hepatic steatosis observed in...

Key Research Findings PT-141 (bremelanotide) demonstrates significant efficacy in treating hypoactive sexual desire disorder through melanocortin 3 and 4 receptor activation Clinical trials show improved Female Sexual Function Index scores with nasal spray...

Key Research Findings PNC-27 demonstrates selective cytotoxicity with IC₅₀ values of 12.4 μM against cervical cancer cells while sparing normal cells Unique mechanism targets HDM-2 proteins exclusively expressed in cancer cell membranes, not normal cells Laboratory...

Key Research Findings Pinealon demonstrates significant neuroprotective effects through ERK 1/2 pathway modulation and reduced reactive oxygen species accumulation Tripeptide Glu-Asp-Arg structure enables direct nuclear penetration and DNA interaction for epigenetic...

Key Research Findings MOTS-c prevents pancreatic islet cell senescence and delays diabetes progression in laboratory models This mitochondrial-derived peptide enhances cellular metabolism through AMPK/SIRT1 pathway activation Recent studies show 48% reduction in...

Key Research Findings Recent studies reveal melanotan significantly increases BDNF levels and enhances TrkB receptor sensitivity in hippocampal research models Melanocortin receptor 4 (MC4R) agonist activity demonstrates potent appetite suppression and metabolic...

Key Research Findings Phase 3 GLORY-1 trial demonstrated 14.01% weight reduction at 48 weeks with 6mg dose Dual GLP-1/glucagon receptor mechanism provides enhanced metabolic effects vs single agonists 82% of participants achieved ≥5% weight reduction in Chinese...

Key Research Findings LL-37 demonstrates potent antimicrobial activity against fungi with 99.91% inhibition rates in 2025 studies Human cathelicidin LL-37 promotes LDL cholesterol clearance and prevents hepatic lipid accumulation Recent research confirms LL-37's role...

Key Research Findings Clinical studies show minimal adverse events with proper research protocols Liposomal formulations demonstrate enhanced bioavailability and reduced systemic effects Research indicates 85% tolerability rates in controlled laboratory settings...